乳がん治療の“いま”〜最新情報と副作用対策

乳がん治療の“いま”〜最新情報と副作用対策

by 田根 香織 (兵庫県立がんセンター乳腺外科部長／神戸大学大学院医学研究科 乳腺内分泌外科学)

Life & Natural Systems Medicine & Health MJCLOncologyMJCL2Chemotherapy
🎙 田根 香織 (兵庫県立がんセンター乳腺外科部長／神戸大学大学院医学研究科 乳腺内分泌外科学) 👥 5K 📅 August 20, 2026 ⏱ 40 min 👁 149 📄 expert opinion 🧭 2026-08-20
Available in: English (current) Français

Keywords

breast cancerside effectstreatmentlymphedemacardiotoxicity

Summary

This video is an archived lecture from the 32nd Cancer Specialist Direct Live event, featuring Dr. Kaori Tane, a breast surgeon at Hyogo Cancer Center. The presentation covers updates in breast cancer treatment, focusing on side-effect management. Dr. Tane discusses the classification of breast cancer by subtype (Luminal A/B, HER2, triple-negative) and staging, emphasizing individualized treatment based on recurrence risk. She highlights the concept of escalation/de-escalation in therapy, aiming to reduce unnecessary treatment for low-risk patients. For metastatic breast cancer, she explains that systemic therapy is the mainstay, with surgery reserved for symptom control or specific cases like oligometastasis. The lecture then addresses common side effects: post-surgical pain, lymphedema, endocrine therapy side effects, hair loss, and cardiovascular risks. She provides practical advice for patients, such as monitoring symptoms, maintaining a healthy lifestyle, and communicating effectively with healthcare providers. The Q&A session clarifies that routine imaging after early breast cancer does not improve survival, and discusses the availability of a cardiovascular follow-up notebook. The video emphasizes the importance of patient involvement in clinical trials and patient associations.

176 words

Critical Evaluation

Value of the Information & Strength of the Argument

The video provides valuable, up-to-date information on breast cancer treatment and side-effect management, directly from a specialist. The argumentation is solid, based on clinical experience and reference to ongoing trials. The speaker clearly explains complex concepts like oligometastasis and de-escalation, making them accessible. The Q&A section adds practical value, addressing common patient concerns with evidence-based responses.

Scientific Rigor, Source Quality, Title Accuracy

The presentation demonstrates scientific rigor, referencing clinical trials and guidelines, though specific citations are not always provided. The speaker mentions the patient guideline (available online) and ongoing trials like JCOG. The title accurately reflects the content, which is a balanced update on treatment and side-effect management. The video is from a reputable source (Japanese Society of Medical Oncology) and features a qualified expert.

134 words

Title / Content Match

The title accurately reflects the content: a review of current breast cancer treatment and side-effect management.

Quality & Reliability

8/10

Presentation by a specialist (breast surgeon) from a recognized cancer center, with references to clinical trials and guidelines. Some claims lack specific citations, but overall content aligns with current medical knowledge.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

Concurring Sources

Contribution & Novelties

The video provides an expert update on breast cancer treatment, emphasizing side-effect management and patient-centered care. It highlights recent advances in drug therapy and the importance of individualized treatment. The Q&A section offers practical insights into managing common concerns like lymphedema and cardiovascular risks.

Pour aller plus loin :

  • Breast cancer treatment guidelines (NCCN) — Relevant for evidence-based treatment recommendations.
  • Oligometastasis concept — Explains the concept of limited metastases and its treatment implications.
  • Cardio-oncology — Discusses cardiovascular risks in cancer patients, relevant to the video’s discussion on cardiotoxicity.

88 words

Radar Profile

The radar profile shows high scores in information quantity, quality, and reliability, with a slightly lower technical level, indicating a balanced presentation suitable for a general audience with some medical background.

Reliability 8/10

💬 No comments were provided for analysis.